Diagnostic Approaches for Giardia Infection

Recommended Diagnostic Methods

The American Gastroenterological Association provides a strong recommendation (high-quality evidence) for testing Giardia in patients with chronic diarrhea, specifying two optimal approaches: Giardia antigen detection tests (enzyme immunoassay/EIA) and polymerase chain reaction (PCR/NAAT) on a single stool specimen 1, 2
Giardia antigen detection tests (enzyme immunoassay/EIA) demonstrate sensitivity and specificity both exceeding 95% 1, 2, 3
Polymerase chain reaction (NAAT) offers excellent performance characteristics with sensitivity and specificity >95% 1, 2, 3
The Infectious Diseases Society of America lists NAAT as an optimal diagnostic procedure for Giardia lamblia 5, 6

Only a single stool specimen is required with modern antigen or molecular tests, unlike the traditional ova and parasite (O&P) examination which requires three specimens collected on different days to achieve adequate sensitivity 7
The traditional microscopic O&P examination has substantial limitations, including low sensitivity (74% compared to 96% for immunoassay), labor-intensive and time-consuming, requires highly trained personnel, and high variability due to intermittent cyst excretion 8, 7
Estimated cost per significant organism identified is $1,836 7

The optimal specimen is a diarrheal stool sample (one that takes the shape of the container) 6
Fresh stool is preferred for protozoal agent identification 6

Testing for Giardia is specifically recommended in patients presenting with chronic diarrhea (strong recommendation) 1, 2
Testing for Giardia is also recommended in returning travelers with severe or persistent symptoms, patients who fail empiric therapy, and presence of bloody diarrhea or mucus in stools 8, 9
Giardia testing should be prioritized in patients with exposure to endemic areas or drinking untreated/contaminated water, hikers drinking untreated water from streams or lakes, exposure in daycare settings, men who have sex with men, and immunodeficiency states 7, 2

Newer FDA-approved multiplex molecular panels, such as the xTAG Gastrointestinal Pathogen Panel and the FilmArray GI Panel, are available but their role is still evolving 8, 9
These panels have high sensitivity and specificity, but molecular testing may detect colonization rather than active infection in some cases, making interpretation difficult 8, 9

Order a Giardia-specific antigen test (EIA) or PCR/NAAT on a single stool specimen 1, 2, 5, 6
Avoid routine O&P examination for Giardia detection due to poor sensitivity 1, 2, 7
If high clinical suspicion persists despite negative testing, consider empiric treatment trial 7
Do not order routine O&P for other parasites in patients without travel history to or recent immigration from high-risk areas 1, 2, 3